MODERATE
60
The Alpha Score is an informational signal based on public SEC fillings. It is not investment advice.
CEOJOURNAL SIGNAL SUMMARY·GENERATED FROM PUBLIC SEC FILINGS
Ashley McEvoy made an open-market purchase of Insulet Corp on 2026-02-20, investing approximately $1,029,205. This is a CEOJournal signal summary placeholder — full narrative pending Claude Haiku enrichment.
Summary based on Form 4 filings and DEF 14A proxy data. Not investment advice. Updated on new filing activity.
Score Components
COMPOSITE ALPHA SCORE
60
Score calculated from open-market purchases only; 10b5-1 preplanned trades excluded; not investment advice.
OPPORTUNISM
Proxy from ownership-change magnitude. Real Opportunism signal will use %52W proximity once price data is in pipeline.
CONVICTION
Log-scaled from trade size. Real Conviction signal will use trade $ ÷ total compensation once DEF 14A data is in pipeline.
PATTERN
Placeholder — 90-day qualifying buy count requires historical Form 4 scrapes (Phase 2).
CLUSTER
Count of other insiders buying the same ticker in our current dataset window.
TRACK RECORD
Placeholder — executive tenure × prior buy P&L requires historical price tracking (Phase 2).
FORM 4 TRANSACTION HISTORYSOURCE: SEC EDGAR
| DATE | TRANSACTION TYPE | CODE | SHARES | PRICE | TOTAL VALUE | 10b5-1 | SCORE |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Open-Market Purchase | P | 4,300 | $239.35 | $1,029,205 | N/A | 60 |
Data sourced from SEC EDGAR Form 4 filings, updated within 24 hours.
Only transaction code P (open-market purchase) qualifies for Alpha Score calculation.
Only transaction code P (open-market purchase) qualifies for Alpha Score calculation.
EXECUTIVE PROFILE
Ashley McEvoy
Pres, CEO
Ashley A. McEvoy has served as President and Chief Executive Officer of Insulet Corporation since April 2025. She is the former Executive Vice President, Worldwide Chairman of MedTech at Johnson & Johnson, a position she held from 2018 to 2023, where she was responsible for the company’s surgery, orthopaedics, interventional solutions, and eye health businesses. During her tenure at J&J, McEvoy led significant businesses, driving strategic investments in innovation platforms and commercial executions that delivered substantial growth.
EDUCATION
- University of Pennsylvania (Bachelor of Arts in Communications and Business)
BOARD SEATS
- The Procter and Gamble Company · Board Member
COMPENSATION & OWNERSHIP ·SOURCE: DEF 14A PROXY
ANNUAL BASE SALARY
$729,808
TOTAL COMPENSATION
$18,858,968
SHARES HELD
13,920
EST. HOLDINGS VALUE
$2.02M
as of May 30, 2026 close
Summary based on Form 4 filings and DEF 14A proxy data. Not investment advice. Updated on new filing activity.
RELATED SIGNALS